| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |